Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology (Q34364491)

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Generalized gangliosidosis: beta-galactosidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Genetic heterogeneity in GM1-gangliosidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Macular cherry-red spots and myoclonus with dementia: Coexistent neuraminidase and β-galactosidase deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Mucolipidosis I: increased sialic acid content and deficiency of an alpha-N-acetylneuraminidase in cultured fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Genetic heterogeneity in human neuraminidase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Correction of combined beta-galactosidase/neuraminidase deficiency in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Enhanced proteolytic degradation of normal beta-galactosidase in the lysosomal storage disease with combined beta-galactosidase and neuraminidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Beta-galactosidase-neuraminidase deficiency: restoration of beta-galactosidase activity by protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Characterization of purified human liver acid β-d-galactosidases A2 and A3

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Purification and characterization of GM1 ganglioside β-galactosidase from normal feline liver and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Intergenic complementation after fusion of fibroblasts from different patients with β-galactosidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The interrelation between high- and low-molecular-weight forms of GM1-beta-galactosidase purified from porcine spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human placental β-galactosidase: structural and immunological observations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Purification of acid beta-galactosidase and acid neuraminidase from bovine testis: evidence for an enzyme complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

In vitro activation of neuraminidase in the beta-galactosidase-neuraminidase-protective protein complex by cathepsin C

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Activation of human lysosomal sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Association of N-acetylgalactosamine-6-sulfate sulfatase with the multienzyme lysosomal complex of beta-galactosidase, cathepsin A, and neuraminidase. Possible implication for intralysosomal catabolism of keratan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The carboxypeptidase nature of cathepsin A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Purification and Some Properties of Cathepsin A of Small Molecular Size from Pig Kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Substrate Specificities of Cathepsin A,L and A,S from Pig Kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Isolation and some properties of cathepsin A from bovine spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Studies on cathepsins of rat liver lysosomes. I. Purification and multiple forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Studies on Cathepsins of Rat Liver Lysosomes. III. Hydrolysis of Peptides, and Inactivation of Angiotensin and Bradykinin by Cathepsin A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Deficient lysosomal carboxypeptidase activity in galactosialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Direct affinity purification and supramolecular organization of human lysosomal cathepsin A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Serine carboxypeptidases: a new and versatile family of enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Continuous spectrophotometric assay of human lysosomal cathepsin A/protective protein in normal and galactosialidosis cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Carboxypeptidases C and D

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Comparative modeling of substrate binding in the S1' subsite of serine carboxypeptidases from yeast, wheat, and human

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A fluorometric assay for measuring deamidase (lysosomal protective protein) using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Inhibition of cathepsin A activity by the potato protease inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Homologous modeling of the lysosomal protective protein/carboxypeptidase L: structural and functional implications of mutations identified in galactosialidosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Three-dimensional structure of the human 'protective protein': structure of the precursor form suggests a complex activation mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A human protective protein gene partially overlaps the gene encoding phospholipid transfer protein on the complementary strand of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Distribution of lysosomal protective protein in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Stoichiometry of the human lysosomal carboxypeptidase-beta-galactosidase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Conversion of met-enkephalin-Arg6-Phe7 by a purified brain carboxypeptidase (cathepsin A)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Conversion of Angiotensin I to Angiotensin II by cathepsin A isoenzymes of porcine kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Molecular biology and biochemistry of the endothelins

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Inactivation of endothelin-1 by an enzyme of the vascular endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Protective protein as an endogenous endothelin degradation enzyme in human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Role of neutral endopeptidase in the metabolism of endothelin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Mouse model for the lysosomal disorder galactosialidosis and correction of the phenotype with overexpressing erythroid precursor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cytochemical detection of a senescence-associated beta-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Acid beta-galactosidase from human fibroblasts. A microscale purification method monitored by a highly sensitive enzyme assay

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Microassay for GM1 ganglioside beta-galactosidase activity using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Stimulation of acid β-galactosidase activity by chloride ions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Antagonistic action of chondroitin sulphate and cetylpyridinium chloride on human liver β-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Chloride ions cancel out inhibition of β-galactosidase activity by acid mucopolyaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Inhibition of human liver beta-galactosidases and beta-glucosidase by n-bromoacetyl-beta-D-galactosylamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Specific inactivation of lysosomal glycosidases in living fibroblasts by the corresponding glycosylmethyl-p-nitrophenyltriazenes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Glycosphingolipid degradation and animal models of GM2-gangliosidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Identification of Glu-268 as the catalytic nucleophile of human lysosomal beta-galactosidase precursor by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The chromosomal localization of human beta-galactosidase revisited: a locus for beta-galactosidase on human chromosome 3 and for its protective protein on human chromosome 22

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Isolation, characterization, and mapping of a human acid beta-galactosidase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Assignment of human ?-galactosidase-A gene to 3p21.33 by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the beta-galactosidase precursor in galactosialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Maturation and degradation of beta-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

THE AGGLUTINATION OF RED CELLS BY ALLANTOIC FLUID OF CHICK EMBRYOS INFECTED WITH INFLUENZA VIRUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Product of interaction between influenza virus enzyme and ovomucin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Bacterial sialidases--roles in pathogenicity and nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Two genetically different MU-NANA neuraminidases in human leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Immunological discrimination of intralysosomal, cytosolic, and two membrane sialidases present in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Expression of a novel human sialidase encoded by the NEU2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cloning, expression, and chromosomal mapping of a human ganglioside sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Immunohistochemical evidence for the existence of rat cytosolic sialidase in rat skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Involvement of an endogenous sialidase in skeletal muscle cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Suppression of pulmonary metastasis in murine B16 melanoma cells by transfection of a sialidase cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human placental sialidase: partial purification and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human Placental Sialidase: Further Purification and Characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Identification of a sialidase encoded in the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neula allele

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cloning of the cDNA and Gene Encoding Mouse Lysosomal Sialidase and Correction of Sialidase Deficiency in Human Sialidosis and Mouse SM/J Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A point mutation in the neu-1 locus causes the neuraminidase defect in the SM/J mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Structures of sialyl-oligosaccharides excreted in the urine of a patient with mucolipidosis I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Structure of nine sialyl-oligosaccharides accumulated in urine of eleven patients with three different types of sialidosis. Mucolipidosis II and two new types of mucolipidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

360-MHz 1H nuclear-magnetic-resonance spectroscopy of sialyl-oligosaccharides from patients with sialidosis (mucolipidosis I and II)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Isolation and structural characterization of sialic acid-containing storage material from mucolipidosis I (sialidosis) fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Abnormal glycosphingolipid metabolism in the nervous system of galactosialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

beta-Galactosidase-neuraminidase deficiency (galactosialidosis): clinical, pathological, and enzymatic studies in a postmortem case

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Degradation of gangliosides by the lysosomal sialidase requires an activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Apoptotic Cell Death in Mouse Models of GM2 Gangliosidosis and Observations on Human Tay-Sachs and Sandhoff Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Sialidase-mediated depletion of GM2 ganglioside in Tay-Sachs neuroglia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Molecular and structural studies of Japanese patients with sialidosis type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The infantile form of sialidosis type II associated with congenital adrenal hyperplasia: possible linkage between HLA and the neuraminidase deficiency gene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Gene for neuraminidase activity on mouse chromosome 17 near h-2: pleiotropic effects on multiple hydrolases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Multiple Forms of Mammalian Sialidase. Altered Expression in Carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Differential effect of various inhibitors on four types of rat sialidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Activation of T lymphocytes results in an increase in H-2-encoded neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Biogenesis of lysosomal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Clathrin coat construction in endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Clathrin and adaptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Ganglioside control over IL-4 priming and cytokine production in activated T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Activated T-lymphocytes express class I molecules which are hyposialylated compared to other lymphocyte populations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Deficiencies of glucosamine-6-sulfate or galactosamine-6-sulfate sulfatases are responsible for different mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

N-acetylgalactosamine-6-sulfate sulfatase in man. Absence of the enzyme in Morquio disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Purification and properties of N-acetylgalactosamine 6-sulphate sulphatase from human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Morquio disease: isolation, characterization and expression of full-length cDNA for human N-acetylgalactosamine-6-sulfate sulfatase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

N-Acetylgalactosamine-6-Sulfate Sulfatase in Human Placenta: Purification and Characteristics1

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A sensitive procedure for the diagnosis of N-acetyl-galactosamine-6-sulfate sulfatase deficiency in classical Morquio's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A fluorimetric enzyme assay for the diagnosis of Morquio disease type A (MPS IV A)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Biochemical and structural analysis of missense mutations in N-acetylgalactosamine-6-sulfate sulfatase causing mucopolysaccharidosis IVA phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Mucopolysaccharidosis IV A: assignment of the human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene to chromosome 16q24

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Morquio A syndrome: cloning, sequence, and structure of the human N-acetylgalactosamine 6-sulfatase (GALNS) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Mucopolysaccharidosis IV A: molecular cloning of the human N-acetylgalactosamine-6-sulfatase gene (GALNS) and analysis of the 5'-flanking region

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Characteristics of the beta-galactosidase-carboxypeptidase complex in GM1-gangliosidosis and beta-galactosialidosis fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human lysosomal beta-galactosidase-cathepsin A complex: definition of the beta-galactosidase-binding interface on cathepsin A

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Purification and partial characterization of lysosomal neuraminidase from human placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Protective protein in the bovine lysosomal β-galactosidase complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Demonstration of enzyme associations by countermigration electrophoresis in agarose gel

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Regulation of the GM1-galactosidase supramolecular structure and catalytic activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Stabilizing effect of lysosomal beta-galactosidase on the catalytic activity of protective protein/cathepsin A secreted by human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Human placental sialidase complex: characterization of the 60 kDa protein that cross-reacts with anti-saposin antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Molecular cloning of a full-length cDNA for human alpha-N-acetylgalactosaminidase (alpha-galactosidase B)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

beta-Galactosidase deficiency in juvenile and adult patients. Report of six Japanese cases and review of literature

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

G-M1-gangliosidosis. Correlation of clinical and biochemical data

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Chemical pathology of G-m-1-gangliosidosis (generalized gangliosidosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Chronic GM1 gangliosidosis presenting as dystonia: II. Biochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cerebral GM1-gangliosidosis: chemical pathology of visceral organs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

GM1-gangliosidosis without chondrodystrophy or visceromegaly. B-galactosidase deficiency with gangliosidosis and the excessive excretion of a keratan sulfate

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Isolation and characterization of keratan sulfates from the liver of a patient with GM1-gangliosidosis type I

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Morquio-B disease, spondyloepiphyseal dysplasia associated with acid beta-galactosidase deficiency. Report of three cases in one family

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Progressive mental regression in siblings with Morquio disease type B (mucopolysaccharidosis IV B).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Morquio-like syndrome with beta galactosidase deficiency and normal hexosamine sulfatase activity: Mucopolysaccharidosis IVB

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

beta-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The biochemistry and clinical features of galactosialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Protective protein gene mutations in galactosialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cherry-red spot myoclonus syndrome (type I sialidosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Disorders of glycoprotein degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Macular cherry-red spot and myoclonus syndrome. Juvenile form of sialidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The cherry red spot-myoclonus syndrome: a newly recognized inherited lysosomal storage disease due to acid neuraminidase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

The cherry-red spot-myoclonus syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Cherry-Red Spot-Myoclonus Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Isolated acid neuraminidase deficiency: A distinct lysosomal storage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Sialidosis type 2 (acid neuraminidase deficiency): clinical and biochemical features of a further case.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

A severe infantile sialidosis: clinical, biochemical, and microscopic features

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Neuraminidase deficiency presenting as non-immune hydrops fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Role of Vibrio cholerae neuraminidase in the function of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Lysosomal and plasma membrane ganglioside GM3 sialidases of cultured human fibroblasts. Differentiation by detergents and inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021

Lysosomal sialidase deficiency: increased ganglioside content in autopsy tissues of a sialidosis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6603%2801%2969045-7

7 January 2021